A Boston Scientific vaginal mesh lawsuit claims the Obtryx II mesh is defectively designed, leading to unreasonable health risks for patients.
Boston Scientific will pay $187 million to resolve claims by most states that it misled both women and state health agencies over the safety and efficacy of transvaginal mesh products.
C.R. Bard will pay $60 million to resolve claims with most states that its transvaginal mesh products were deceptively advertised.
A California judge wants Johnson & Johnson to pay $344 million to the state for falsely advertising the safety of its vaginal mesh products.
Johnson & Johnson and Ethicon have agreed to pay 41 states nearly $117 million to settle charges of deceptive marketing and defrauding state health care systems over the safety and…
Johnson & Johnson faces more than 100,000 lawsuits over problems with its products, which may cost up to $50 billion to settle.
Two new studies provide more evidence that vaginal mesh carry few, if any, benefits, and that there is little which can be done to improve them.
A vaginal mesh lawsuit indicates Boston Scientific mesh devices caused severe injuries, complications and the need for surgery.
Johnson & Johnson has reached a $9.9 million settlement agreement to resolve a lawsuit by the state of Washington claiming it endangered women by failing to warn about the risks…
The FDA has banned the sale and distribution of transvaginal mesh products in the United States, saying they cannot guarantee the devices are safe or effective for women.
